The Board of Directors of Nymox Pharmaceutical Corporation confirmed the appointment of Randall J. Lanham, Esq. as the company's Secretary and General Counsel. Mr. Lanham has been a board member for eight years and is now reappointed as a board member and an officer.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.161 USD | -5.29% | -23.33% | -72.71% |
1st Jan change | Capi. | |
---|---|---|
-72.71% | 15.03M | |
+23.26% | 47.96B | |
+0.44% | 42.45B | |
+43.96% | 41.47B | |
+25.70% | 31.6B | |
+20.67% | 28.63B | |
-4.47% | 28.03B | |
+51.47% | 14.56B | |
+44.86% | 14.14B | |
+1.91% | 12.58B |
- Stock Market
- Equities
- NYMXF Stock
- News Nymox Pharmaceutical Corporation
- Nymox Pharmaceutical Corporation Announces Appointment of Randall J. Lanham, Esq. as the company’s Secretary and General Counsel